Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · IEX Real-Time Price · USD
1.055
+0.005 (0.47%)
May 3, 2024, 11:24 AM EDT - Market open

Oragenics Revenue

In the year 2023, Oragenics had annual revenue of $37.65K, a decrease of -71.37%.

Revenue (ttm)
$37.65K
Revenue Growth
-71.37%
P/S Ratio
124.95
Revenue / Employee
$7,531
Employees
5
Market Cap
4.79M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202337.65K-93.87K-71.37%
Dec 31, 2022131.52K44.53K51.20%
Dec 31, 202186.99K--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 2014939.93K-92.31K-8.94%
Dec 31, 20131.03M-299.53K-22.49%
Dec 31, 20121.33M-112.68K-7.80%
Dec 31, 20111.44M135.54K10.35%
Dec 31, 20101.31M667.63K104.11%
Dec 31, 2009641.29K407.75K174.59%
Dec 31, 2008233.54K100.45K75.48%
Dec 31, 2007133.09K66.91K101.11%
Dec 31, 200666.18K--
Dec 31, 20050--
Dec 31, 2004196.21K--
Dec 31, 20030--
Dec 31, 20020--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BIOLASE 49.16M
SunLink Health Systems 39.59M
Petros Pharmaceuticals 5.82M
Aditxt 645.18K
Lipella Pharmaceuticals 449.62K
Assure Holdings 255.00K
Revenue Rankings